Skip to main content

Whipsaw week, deteriorating internals

Nifty fell 0.9% with a mid-week rout; Stage-2 share hit a six-week low as the tape stayed stuck in transition.

Friday, 25 September 20263 min readStage2Stocks Market Desk

Nifty 50
23,141
-0.9% on the week
Market
Neutral — Fading
18 sessions in this state
Breadth
40%
above 200-DMA · narrowed from 40%
Stage 1→2 (wk)
23
net -51 vs 2→3
52w highs / lows
146 / 187
net -41
Stage-2 share
31%
-33 stocks this week

The index closed the week down 0.9% at 23,140, still under its 200-day average and 12% off its high, but the headline number flatters what actually happened. Wednesday alone wiped out the week: advancers fell to 552 against 1,927 decliners, the sharpest one-day drop in six weeks. Thursday and Friday clawed back some ground, but breadth never recovered its footing. The regime label has now sat in transition for 18 straight sessions, and the near-term read stays neutral-to-down.

The bounce is thinner than it looks

Friday's advance-decline line came in almost dead even, 1,242 to 1,230, which is a poor recovery after Wednesday's rout. The share of stocks above the 200-day average slipped from 39.8% to 39.5% across the week — not a collapse, but the wrong direction for a market already below its long-term average on the index itself. New highs versus new lows stayed net negative all week, closing at 146 highs against 187 lows. None of that screams panic, but none of it screams turn either.

Stage-2 cohort keeps shrinking

This is the real story of the week. The Stage-2 share — the slice of the market actually in an advancing trend — fell to 30.7% of the universe, its lowest point in six weeks, down from 38.6% just five weeks ago. Twenty-three stocks moved from Stage 1 into Stage 2 over the past five sessions; seventy-four slid from Stage 2 into Stage 3. That net of minus-51 is close to the worst five-day reading of the past month, and the broader run of negative net transitions has now persisted for 22 sessions running. Golden crosses have thinned out to just four, matched by four death crosses — both well down from the sixteen golden crosses seen in mid-August. Median setup scores across the screen sit at a six-week low too. Put together, this is a market with fewer stocks earning the right to be called trending, not more.

Energy quietly broadens while price leaders fade

Real Estate led the week on price, up 2.9%, and Consumer Staples added 1%. But Real Estate's own Stage-2 share has been shrinking hard — down nearly 7 points over the past month even as the sector's price ticked higher, a sign the move is being carried by fewer names, not more. Communication Services was the week's clear laggard, down 3.4%, and Financials gave back 1.6%. The more interesting divergence sits in Energy: the sector was flat to slightly positive on the day and unremarkable on the weekly sector table, yet its Stage-2 share has jumped over 20 points in the past month to 55%, the widest expansion on the screen. That's being driven by oilfield equipment and exploration names quietly building bases while the market's attention sits elsewhere. Health Care remains the steadiest performer over one and three months, even as its own Stage-2 share edges down slightly — a mature trend rather than a fresh one.

Where the setups sit

The early-stage list — Stage-2 names that haven't run far from their 50-day average yet — is led by Nocil, with Wockhardt, SoftTech Engineers, Strides Pharma and Maharashtra Seamless close behind, spanning Materials, Health Care, IT and Industrials rather than one crowded corner. The most extended names on the screen — Bhageria Industries, Spectrum Electrical, Raymond and Kopran among them — carry the highest setup scores precisely because they've already made their move; treat that list as a read on current leadership, not a shopping list. Against a backdrop of narrowing participation and a shrinking Stage-2 pool, this is a week for selectivity over conviction — the screen is still finding candidates, but the market underneath them is offering less cover than it was a month ago.

This week's stage transitions
StockSectorMoveSetup
Shivalik Rasayan LtdMaterials1→28.2
Parag Milk Foods LtdConsumer Staples1→27.3
Man Infraconstruction LtdIndustrials1→26.3
Kotak Mahindra Bank LtdFinancials1→26.0
Heritage Foods LtdConsumer Staples1→25.3
Kaya LtdConsumer Discretionary1→25.0
Punjab National BankFinancials1→23.8
V Guard Industries LtdIndustrials1→23.8
Sustained Stage-2 setups (score ≥ 7)
StockSectorSetupRS
Bhageria Industries LtdMaterials10.096
Spectrum Electrical Industries LtdIndustrials10.097
Raymond LtdConsumer Discretionary10.095
Kopran LtdHealth Care9.892
Shree Pushkar Chemicals & Fertilisers LtdMaterials9.884
Yatharth Hospital & Trauma Care Services LtdHealth Care9.487
Rossell Techsys LtdIndustrials9.495
Arrow Greentech LtdMaterials9.490
Sector performance — cap-weighted, ranked by today’s move
Sector1D1M3MRSStage 2
Real Estate+0.7%-2.8%+8.2%5520%
Utilities+0.6%-2.2%-8.5%5715%
Consumer Discretionary+0.5%-2.8%+7.2%5932%
Materials+0.5%-3.0%+2.2%6437%
Consumer Staples+0.4%-2.6%-3.7%4732%
Financials+0.3%-4.6%-3.5%5729%
Industrials+0.3%-2.1%-0.2%6625%
Energy+0.2%-3.4%-2.1%5655%
Information Technology-0.0%-5.4%+3.3%4224%
Health Care-0.3%+1.2%+8.4%7248%
Communication Services-0.5%-4.4%+4.5%5822%
Share of NSE stocks in Stage 2Mar 2026 – Sep 2026 · weekly
0%10%20%30%40%50%60%70%Jul 26Nifty 50Stocks in Stage 2Latest: 31%
The share of NSE stocks in Stage 2 over the six months to this wrap, with the Nifty's shape above it — the market underneath the day's numbers. Source: Stage2Stocks classification of every NSE stock with enough history, each week.
Try it on Stage2StocksHow to read this chart Lesson 3 of the course: why the Nifty isn't the market, and what the share of stocks in Stage 2 tells you.

Work the same data live: open the full stock screener, watch the live market dashboard, or check the market-timing read. New to the method? Start with the four stages.

Stage2Stocks is an educational stage-analysis screener. These wraps describe what the screen shows across NSE cash equities — they are not investment advice, recommendations, or buy/sell calls. Always do your own research.

All market wraps →